FIND IN free and premium articles free articles only premium articles only this publication Arts Autos Business Health Home & Garden News Reference Sports TechnologyAdvancedSearch (Related)
Top 20 pharma companies: while the US saw a rebound in prescription drug growth in 2006, few companies are sitting pretty. Matthew Arnold charts the trends, events, stories and numbers of the biggest players.(Company rankings)
Innovative new oncology drugs and an increase in prescribing volume due to Medicare Part D drove a rebound in US prescription drug growth of 8.3% for 2006, up from 5.4% in 2005, according to data from IMS Health. Total US sales reached $274.9 billion.
The global market grew 7% for the year, to $643 billion.
Most Popular Articles
in HealthCocktails and... (Related) The best damn chest... (Related) The sour truth about... (Related) The best self-tanners:... (Related)
in HealthCocktails and... (Related) The best damn chest... (Related) The sour truth about... (Related) The best self-tanners:... (Related)
Most Popular Publications
in HealthShape (Related) Men's Fitness (Related) Nutrition Forum (Related) AORN Journal (Related)
in HealthShape (Related) Men's Fitness (Related) Nutrition Forum (Related) AORN Journal (Related)
Growth in many primary care-oriented categories, including PPIs, antihistamines, platelet aggregation inhibitors and antidepressants, continued to slow while sales of generics--which represented more than half of total volume for the top seven markets--progressed. Sales of ...
Read the rest of this article with a Free Trial at HighBeam Research. (Related)
No comments:
Post a Comment